dihexa approval status fda Peptide Therapy Dihexa Capsules 10mg (30ct) |

It's well-tolerated with minimal side effects

You do not have permission under this licence to share adapted material derived from this article or parts of it

For obesity treatment, dose escalation protocols starting at lower doses (e.g., 2 mg) and gradually increasing to maintenance doses (e.g., 4 mg, 8 mg, or 12 mg) have been studied Product Overview: Cagrilintide (5mg) is a research peptide, Cagrilintide, an amylin analog

Q2: What is cagrilintide's half-life

Phase 3 data showed lower rates of nausea and vomiting compared to GLP-1 therapiespotentially better tolerated for some patients

Discontinuation due to adverse events was about 4% across all dose groups